611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Cancer
Resources
Basic InformationLatest News
Race Doesn't Affect Risk for Genes That Raise Breast Cancer RiskHealthy Levels of Vitamin D May Boost Breast Cancer OutcomesStudy Pinpoints Cancer Patients at Highest Risk From COVIDCan You Keep Your Bladder After Bladder Cancer Strikes?Breast Cancer's Spread Is More Likely in Black Women, Study FindsNewly Approved Drug Fights Lung Cancer Tied to Certain GenesDrug Lynparza Could Help Fight Some Early-Stage Breast CancersTargeted Radiotherapy Might Help Men Battling Advanced Prostate CancerOut-of-Pocket Costs Delay Cancer Follow-Up Care, Even for the InsuredDon't Delay Lung Cancer Surgery, Study SuggestsModerate Use of Hair Relaxers Won't Raise Black Women's Cancer Risk: StudyFaulty Gene Could Raise Vulnerability to Asbestos-Linked CancerColonoscopy After 75: A Potential Lifesaver for MostBreast Cancer Treatments Don't Raise COVID RisksImmunotherapy Drug Can Beat Back Early-Stage Lung CancerKey Factors That Raise Your Odds for Early-Onset Colon CancerHPV Vaccination Is Lowering U.S. Cervical Cancer RatesAs Medicaid Access Expands, So Does Cancer SurvivalMS May Not Affect Breast Cancer PrognosisGet First Colonoscopy at 45, not 50: U.S. Expert PanelMelanoma Can Strike Your Nails: Here's How to CheckGene-Targeted Drug Shows Promise Against a Form of Pancreatic CancerObesity Raises Odds for Many Common CancersLockdown Loneliness Making Things Even Tougher for Cancer PatientsLots of Sugary Drinks Doubles Younger Women's Colon Cancer Risk: StudyRelatives' Colonoscopy Results Could Affect Your Colon Cancer RiskAmericans Missed Almost 10 Million Cancer Screenings During PandemicHow the Pandemic Changed Breast Cancer CareFreezing Tumors Could Be New Treatment for Low-Risk Breast CancersMany Americans Wrong About Sun's Skin Cancer Dangers: PollWho's Most Likely to Join a Clinical Trial?Obamacare Gave More Breast Cancer Survivors Access to Breast ReconstructionCancers Far More Common in Medieval Times Than ThoughtWhen Cancer Strikes Those Under 40, Race MattersSecondhand Smoke Can Raise Odds for Mouth, Throat CancersClosely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHAAHA News: Cancer May Cause Changes to the Heart Before TreatmentBreast Cancer Over 70: How Much Treatment Is Enough?New Hope Against a Rare but Incurable Eye CancerIn Breast Cancer Survivors, Obesity Raises Odds for Cancer's ReturnTeen Tanning Bed Ban Would Prevent Thousands of U.S. Melanoma CasesFDA Approves First AI Tool to Boost Colonoscopy AccuracyTherapeutic Cancer Vaccine Shows Promise Against Multiple Tumor TypesCould Widely Used Blood Pressure Meds Raise Skin Cancer Risk?Healthy Living Helps Ward Off Deadly Prostate Cancers in Men at High RiskCOVID Vaccines Might Not Protect Certain Cancer PatientsOvarian Cancer Diagnosis Can Take Big Toll on Women's Mental HealthGuys, Take the Lead in Self-Checks for Testicular CancerThe Future of Cancer for AmericansWhy So Many New Cancer Diagnoses When Americans Turn 65?
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

U.S. Cancer Screening Rates Back to Normal After Pandemic Dip

HealthDay News
by Robert Preidt
Updated: Mar 24th 2021

new article illustration

WEDNESDAY, March 24, 2021 (HealthDay News) -- After a sharp drop early in the COVID-19 pandemic, rates of routine breast and colon cancer screening soon returned to near-normal levels, a new study finds.

"These are the first findings to show that, despite real fears about the consequences of drop-off in cancer screens, health facilities figured out how to pick this back up after the initial pandemic restrictions," said lead study author Ryan McBain. He's a policy researcher at RAND Corporation, a nonprofit research organization.

For the study, researchers analyzed insurance claims from 6.8 million U.S. adults (aged 45 to 64) filed between mid-January and July 31 of last year.

After March 13, 2020, when a national pandemic emergency was declared, the median weekly rate of routine screening mammograms plummeted 96%, from 87.8 per 10,000 beneficiaries to 6.9 per 10,000 in April. (Median means half of weeks had more, half less.)

By the end of July, however, the rate had bounced back to 88.2 per 10,000.

Meanwhile, routine colonoscopy screening rates had a similar decline, falling 95% from 15.1 to 0.9 per 10,000. While the rate rebounded to 12.6 per 10,000 by the end of July, it wasn't enough to offset the initial plunge, according to findings published online March 19 in the Journal of General Internal Medicine.

"Our study shows that health systems were able to recalibrate resources and protocols in a relatively short interval to deliver these important services," McBain said in a RAND news release.

Routine screening procedures such as mammography and colonoscopy are essential for early detection and treatment of cancers, the study authors noted.

When routine screenings plummeted, there were concerns that cancer diagnoses would be delayed, resulting in serious health consequences. Now that rates have rebounded, those who postponed screening should get priority, one researcher suggested.

"While it is reassuring to see cancer screening rates begin to return to pre-pandemic levels, we have to ensure that people who deferred preventive services are prioritized to get their screening in a timely manner, especially if they are at higher risk of disease," said study co-author Dr. Dena Bravata, chief medical officer of Castlight Health, a San Francisco-based company focused on access to care.

More information

The U.S. National Cancer Institute has more on cancer screening.

SOURCE: RAND Corporation, news release, March 22, 2021